Univ. of Tokyo, Astellas to Codevelop Rice-Based Oral Cholera Vaccine

The University of Tokyo’s Institute of Medical Science (IMSUT) and Astellas Pharma will collaborate in the development of the rice-based oral vaccine MucoRice-CTB against cholera and enterotoxigenic E. coli-caused diarrheal diseases. The vaccine was developed by Prof. Hiroshi Kiyono, project...read more